why choose us

First received: March 07, 2023

Clinical Trial: A Study of CDX-0159 in Patients With Eosinophilic Esophagitis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Eosinophilic Esophagitis

Study Type: INTERVENTIONAL


Official Title: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab (CDX-0159) in Adults With Active Eosinophilic Esophagitis (The "EvolvE" Study)

Brief Summary: The purpose of this study is to assess the efficacy and safety of barzolvolimab in adult Eosinophilic Esophagitis patients.

Read more